Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Strong Biotechnologies is a China-based in vitro diagnostics company focused on the research, manufacture, and commercialization of clinical diagnostic reagents and instruments. The company is best known for biochemical diagnostic reagents and has expanded into broader IVD categories including coagulation testing, blood typing and related quality-control products, and diagnostic instrumentation. It is a publicly traded company on the Shenzhen Stock Exchange and operates primarily in China, with a commercial-stage product portfolio rather than a therapeutic drug pipeline. The business appears oriented toward hospital and clinical laboratory customers, combining reagent development, instrument sales, and related diagnostic services. Its profile is much closer to a diagnostics and medical-device manufacturer than to a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Strong Biotechnologies.